As Frontline Centre PURE’s overall mission is implementation of clinical research that will improve diagnostics and management of these heterogeneous diseases.
In this context, PURE have launched clinical studies on a wide range of patients with rheumatoid arthritis, and connective tissue diseases as systemic scleroderma and systemic lupus erythematosus. The common denominator is exploring whether novel diagnostic modalities can improve early disease detection to be used to perform risk stratification profiles for these patients aiming to reduce their morbidity and mortality.
Ongoing Research projects
See full list of ongoing research projects in the research unit
